Double-blind trial of feprazone and phenylbutazone in acute gout. 1980

J A Reardon, and A Stockman, and L G Darlington, and J T Scott

A double-blind trial was carried out in 24 patients with acute gout to compare the efficacy and tolerance of feprazone, a non-steroidal anti-inflammatory drug, with that of phenylbutazone. Patients received 800 mg of either drug daily for 2 days and then 600 mg daily for up to 8 days. The results of patient assessment showed there was no significant difference between the two groups in time taken either to significant improvement or to final resolution of the gout attack. No side-effects were reported with either drug.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D011298 Feprazone A pyrazole that has analgesic, anti-inflammatory, and antipyretic properties. It has been used in mild to moderate pain, fever, and inflammation associated with musculoskeletal and joint disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p15) Fenilprenazone,Phenylprenazone,Prenazone,Brotazona,DA-2370,Zepelin,DA 2370,DA2370
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006073 Gout Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi. Gouts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

J A Reardon, and A Stockman, and L G Darlington, and J T Scott
November 1985, British journal of clinical pharmacology,
J A Reardon, and A Stockman, and L G Darlington, and J T Scott
January 1977, Current medical research and opinion,
J A Reardon, and A Stockman, and L G Darlington, and J T Scott
February 1977, Annals of the rheumatic diseases,
J A Reardon, and A Stockman, and L G Darlington, and J T Scott
September 1976, Wiener klinische Wochenschrift,
J A Reardon, and A Stockman, and L G Darlington, and J T Scott
January 1977, Advances in experimental medicine and biology,
J A Reardon, and A Stockman, and L G Darlington, and J T Scott
February 1978, Annals of the rheumatic diseases,
J A Reardon, and A Stockman, and L G Darlington, and J T Scott
May 1980, Journal of the Oslo city hospitals,
J A Reardon, and A Stockman, and L G Darlington, and J T Scott
May 1976, Rheumatology and rehabilitation,
J A Reardon, and A Stockman, and L G Darlington, and J T Scott
April 1979, Arthritis and rheumatism,
J A Reardon, and A Stockman, and L G Darlington, and J T Scott
July 1973, Annals of the rheumatic diseases,
Copied contents to your clipboard!